The document discusses the importance of testing the toxicity of compounds produced by a company, outlining two main options: traditional bioassays involving live animals and in silico modeling using machine learning. While bioassays are effective, they are costly and time-consuming, requiring extensive resources for multiple tests. In contrast, in silico methods can predict toxicity through molecular descriptors and machine learning techniques, allowing for faster assessment of numerous compounds.